Research statistics
Follistatin-344 research: publications and trials
At a glance
Publications, all years
6
Since 2016
Publications in 2026 so far
2
Through November 15, 2026
Human clinical research
16.7%
1 of 6 classified
Registered clinical trials
0
ClinicalTrials.gov
Randomized controlled trials
0
Publications reporting an RCT in people
Systematic reviews and meta-analyses
0
Preclinical studies
66.7%
2 animal · 2 in vitro · 0 computational
Records that only mention it
0
Not counted above
Status in the library: Research only.
What to keep in mind
- Fewer than three randomized controlled trials are indexed.
- Fewer than 25 publications are indexed, so year-to-year changes are not meaningful.
- The body makes this molecule itself, so much of its literature is physiology rather than research on it as a compound.
Publications by year
Follistatin-344 publications by year and evidence
Show the data
| Year | Human clinical research | Preclinical (animal, in vitro, computational) | Reviews and meta-analyses | Total |
|---|---|---|---|---|
| 2016 | 0 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 0 | 1 |
| 2020 | 1 | 1 | 0 | 2 |
| 2026 (to date) | 0 | 1 | 1 | 2 |
Study types
| Animal study | 2 |
|---|---|
| In vitro study | 2 |
| Observational human study | 1 |
| Review | 1 |
Research areas
From MeSH major topics. A paper can be in several areas.
| Cardiovascular | 2 |
|---|---|
| Musculoskeletal | 2 |
| Tissue repair | 2 |
| Oncology | 1 |
Registered clinical trials
A registration is not a result.
No registered trials.
Human trials and evidence reviews
Meta-analyses, systematic reviews and trials in people, newest first.
No human trial, systematic review or meta-analysis of Follistatin-344 is indexed.
Most cited
By OpenAlex citation count. Citations measure attention, not quality or correctness.
- Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia.
EMBO molecular medicine · March 5, 2020 · In vitro study · cited 17 times · open access
PMID 32134197 · DOI 10.15252/emmm.201910895 · In vitro studies
- The transgenic expression of human follistatin-344 increases skeletal muscle mass in pigs.
Transgenic research · October 27, 2016 · Animal study · cited 16 times
PMID 27787698 · DOI 10.1007/s11248-016-9985-x · Animal studies
- Detection of black market follistatin 344.
Drug testing and analysis · November 1, 2019 · In vitro study · cited 9 times
PMID 31758732 · DOI 10.1002/dta.2741 · In vitro studies
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.
Sports medicine (Auckland, N.Z.) · April 12, 2026 · Review · cited 8 times · open access
PMID 41966639 · DOI 10.1007/s40279-026-02437-0 · Reviews and meta-analyses
- Central serous chorioretinopathy associated with high-dose follistatin-344: a retrospective case series.
International ophthalmology · July 15, 2020 · Observational human study · cited 2 times
PMID 32671599 · DOI 10.1007/s10792-020-01501-6 · Human clinical research
Latest publications
- Follistatin Mitigates Atherosclerosis Through Activation of Arginine Metabolism and Adipose Browning.
Cells · July 2, 2026 · Animal study · cited 0 times · open access
PMID 42439678 · DOI 10.3390/cells15131205 · Animal studies
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.
Sports medicine (Auckland, N.Z.) · April 12, 2026 · Review · cited 8 times · open access
PMID 41966639 · DOI 10.1007/s40279-026-02437-0 · Reviews and meta-analyses
- Central serous chorioretinopathy associated with high-dose follistatin-344: a retrospective case series.
International ophthalmology · July 15, 2020 · Observational human study · cited 2 times
PMID 32671599 · DOI 10.1007/s10792-020-01501-6 · Human clinical research
- Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia.
EMBO molecular medicine · March 5, 2020 · In vitro study · cited 17 times · open access
PMID 32134197 · DOI 10.15252/emmm.201910895 · In vitro studies
- Detection of black market follistatin 344.
Drug testing and analysis · November 1, 2019 · In vitro study · cited 9 times
PMID 31758732 · DOI 10.1002/dta.2741 · In vitro studies
- The transgenic expression of human follistatin-344 increases skeletal muscle mass in pigs.
Transgenic research · October 27, 2016 · Animal study · cited 16 times
PMID 27787698 · DOI 10.1007/s11248-016-9985-x · Animal studies
How this is counted
PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology
Search terms: Follistatin-344; FST-344
((TITLE_ABS:"Follistatin-344" OR CHEM:"Follistatin-344" OR TITLE_ABS:"Follistatin344" OR CHEM:"Follistatin344") OR (TITLE_ABS:"FST-344" OR CHEM:"FST-344" OR TITLE_ABS:"FST344" OR CHEM:"FST344")) AND SRC:MED
Cite this page
Peptide Library. (2026, November 16). Follistatin-344 research statistics (Version weekly-2026-11-15) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/follistatin-344